Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

Ono Pharmaceuticals

Status and phase: Completed; Phase 2

Conditions: Coronary Artery Disease

Treatments: Drug: ONO-1101

Study type: Interventional

Funder types: Industry

Identifiers

NCT00311038

ONO-1101-24

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.

Enrollment: 90 estimated patients

Sex: All

Ages: 20 to 74 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. 20-74 years old
2. Heart rate less than 90 beats/min more than 70 beats/min at entering the CT room

Exclusion criteria

1. Previous allergic reactions to contrast agent
2. Renal failure
3. Asthma
4. Other exclusion criteria as specified in the protocol

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)